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The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the
Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis
David S. Donaldson,a Kathryn J. Else,b Neil A. Mabbotta
The Roslin Institute & Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, United Kingdoma, Faculty of Life Sciences, University of Manchester,
Manchester, United Kingdomb
ABSTRACT
Prion diseases are infectious neurodegenerative disorders characterized by accumulations of abnormally folded cellular prion
protein in affected tissues. Many natural prion diseases are acquired orally, and following exposure, the early replication of some
prion isolates upon follicular dendritic cells (FDC) within gut-associated lymphoid tissues (GALT) is important for the efficient
spread of disease to the brain (neuroinvasion). Prion detection within large intestinal GALT biopsy specimens has been used to
estimate human and animal disease prevalence. However, the relative contributions of the small and large intestinal GALT to
oral prion pathogenesis were unknown. To address this issue, we created mice that specifically lacked FDC-containing GALT
only in the small intestine. Our data show that oral prion disease susceptibility was dramatically reduced in mice lacking small
intestinal GALT. Although these mice had FDC-containing GALT throughout their large intestines, these tissues were not early
sites of prion accumulation or neuroinvasion.We also determined whether pathology specifically within the large intestine
might influence prion pathogenesis. Congruent infection with the nematode parasite Trichuris muris in the large intestine
around the time of oral prion exposure did not affect disease pathogenesis. Together, these data demonstrate that the small in-
testinal GALT are the major early sites of prion accumulation and neuroinvasion after oral exposure. This has important impli-
cations for our understanding of the factors that influence the risk of infection and the preclinical diagnosis of disease.
IMPORTANCE
Many natural prion diseases are acquired orally. After exposure, the accumulation of some prion diseases in the gut-associated
lymphoid tissues (GALT) is important for efficient spread of disease to the brain. However, the relative contributions of GALT in
the small and large intestines to oral prion pathogenesis were unknown.We show that the small intestinal GALT are the essential
early sites of prion accumulation. Furthermore, congruent infection with a large intestinal helminth (worm) around the time of
oral prion exposure did not affect disease pathogenesis. This is important for our understanding of the factors that influence the
risk of prion infection and the preclinical diagnosis of disease. The detection of prions within large intestinal GALT biopsy speci-
mens has been used to estimate human and animal disease prevalence. However, our data suggest that using these biopsy speci-
mens maymiss individuals in the early stages of oral prion infection and significantly underestimate the disease prevalence.
Prion diseases (transmissible spongiform encephalopathies[TSEs]) are subacute neurodegenerative diseases affecting
both animals and humans and are characterized by the accumu-
lation of aggregations of PrPSc, abnormally folded isoforms of the
cellular prion protein (PrPC), in affected tissues. Infectivity copu-
rifies with PrPSc, and it appears to constitute themajor, if not sole,
component of the infectious agent (1). Many prion diseases, in-
cluding natural sheep scrapie, bovine spongiform encephalopa-
thy, chronic wasting disease (CWD) in mule deer and elk, and
kuru and variant Creutzfeldt-Jakob disease (vCJD) in humans, are
acquired peripherally by oral consumption of prion-contami-
nated food.
The gut-associated lymphoid tissues (GALT) comprise a col-
lection of multifollicular structures, including the tonsils, Peyer’s
patches, appendix, colonic and cecal patches, and a number of
smaller, single follicular structures termed isolated lymphoid fol-
licles (ILF). These tissues are situated throughout the gastrointes-
tinal tract, and together with themesenteric lymph nodes (MLN),
they help protect the host from infection. However, following oral
exposure, some prion isolates exploit the GALT to infect the host
(2–4), where they replicate upon follicular dendritic cells (FDC) in
the B-cell follicles before spreading via enteric nerves to the central
nervous system (CNS) (a process termed neuroinvasion) (2–7).
Once the prions have been amplified on the surfaces of FDC above
the threshold required for neuroinvasion, they subsequently in-
fect the enteric nerves within the intestine (8, 9). The prions then
spread through the peripheral nervous system (both sympathetic
and parasympathetic) and infect the CNS (10, 11), although he-
matogenous spread cannot be entirely excluded. Our previous
data suggest that neuroinvasion after oral exposure occurs directly
via GALT since neuroinvasion was blocked in mice that lacked
GALT (3).
The ILF in the intestine can be classified as either immature ILF
(individual primary B-cell follicles) or mature ILF containing a
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single organized B-cell-containing germinal center and an FDC
network (12–16). We have shown that FDC-containing mature
ILF were a novel, previously unrecognized site of prion accumu-
lation and neuroinvasion in the intestine. Mice that lacked orga-
nized patch-like structures such as the Peyer’s patches but con-
tained numerous FDC-containing ILF throughout their intestines
displayed unaltered prion disease pathogenesis and susceptibility
after oral exposure compared to intact control mice (3).
Prions accumulate in both small intestinal (SI) and large intes-
tinal (LI) GALT. Accumulation within LI GALT, such as the
rectoanal mucosa-associated lymphoid tissues (RAMALT) of
scrapie- and CWD-affected species (17, 18) and the appendix of
vCJD-affected humans, has received significant attention, as it has
been used to identify preclinical infected animals and to gain in-
sight into the possible prevalence of vCJD in the United Kingdom
(19, 20). However, the relative contribution of LI GALT in oral
prion disease susceptibility has been mostly overlooked as prion
uptake studies have focused on the uptake of prions directly into
Peyer’s patches in the SI or have analyzed tissues collected toward
the clinical stage of disease, after neuroinvasion has occurred. Im-
portantly, in cases where LIGALThas been studied in natural host
species earlier in disease, it appears that the prion accumulation
within these tissues may occur secondary to that of SI GALT (21–
23). While this may relate in part to sensitivity of detection, it
questions the reliability of sampling LI GALT as a prion diagnos-
tic. Therefore, in this study, mice that were specifically deficient in
FDC-containing GALT only in the SI were created. These were
then used to determine whether the GALT in the SI or the LI were
the important sites of early prion accumulation and subsequent
neuroinvasion after oral exposure. Since the colon is the major
colonization site for commensal bacteria, disturbances to the gut
microbiota or inflammation or pathology within the mucosa or
the GALT in the LI may have significant influence on oral prion
disease pathogenesis. Therefore, we also determined whether the
pathology or inflammation caused by a congruent pathogen in-
fection that was specifically restricted to the LI may influence oral
prion disease pathogenesis.
MATERIALS AND METHODS
Mice. C57BL/6J mice were used throughout this study and maintained
under specific-pathogen-free (SPF) conditions. All studies and regulatory
licenses were approved by theUniversity of Edinburgh’s ethics committee
and carried out under the authority of a UKHomeOffice Project License.
In utero LTR-blockade. Pregnant C57BL/6J mice were injected in-
travenously (i.v.) with 100g of lymphotoxin receptor (LTR)-Ig (Bio-
gen Idec,Weston,MA,USA) (24) on embryonic day 11.5 (E11.5) to block
Peyer’s, cecal, and colonic patch development in the progeny and induce
the development of higher numbers of ILF (12, 14, 15, 25). Some pregnant
mice were injected i.v. with 100g human IgG (hu-IgG) as a control. The
formation of ILF, Peyer’s patches, and their patch-like counterparts in the
LI is LTR dependent. However, unlike Peyer’s patches and their patch-
like counterparts in the LI, ILF formation occurs postnatally. Thus, al-
though in utero LTR-signaling blockade prevents the development of
Peyer’s, cecal, and colonic patches, the postnatal development of ILF from
cryptopatches throughout the SI and LI is conserved (12, 14, 15, 25).
Prion exposure and disease monitoring. For oral exposure, mice
were fed individual food pellets doused with 50 l of a 1.0% (wt/vol)
dilution of scrapie brain homogenate prepared from mice terminally af-
fected with ME7 scrapie prions (containing approximately 2.5 104 in-
tracerebral [i.c.] 50% infective dose [ID50] units) according to our stan-
dard protocol (3, 5, 26, 27). To do so, during the dosing periodmice were
individually housed in bedding- and food-free cages. Water was provided
ad libitum. A single prion-dosed food pellet was then placed in the cage.
The mice were returned to their original cages (with bedding and food ad
libitum) as soon as the food pellet was observed to have been completely
ingested. The use of bedding-free and additional food-free cages ensured
easy monitoring of consumption of the prion-contaminated food pellet.
Following prion exposure, mice were coded and assessed weekly for signs
of clinical disease and culled at a standard clinical endpoint. The clinical
endpoint of disease was determined by rating the severity of clinical signs
of prion disease exhibited by themice. Following clinical assessment,mice
were scored as “unaffected,” “possibly affected,” and “definitely affected”
using standard criteria that typically present in mice clinically affected
with ME7 scrapie prions. Clinical signs following infection with the ME7
scrapie agent may include weight loss, starry coat, hunched posture,
jumpy behavior (at early onset) progressing to limitedmovement, upright
tail, wet genitals, decreased awareness, discharge from eyes/blinking eyes,
and ataxia of hind legs. The clinical endpoint of disease was defined in one
of the following ways: (i) the day on which a mouse received a second
consecutive “definite” rating; (ii) the day on which a mouse received a
third “definite” rating within four consecutive weeks; (iii) the day on
which a mouse was culled in extremis. Survival times were recorded for
mice that did not develop clinical signs of disease and were culled when
they showed signs of intercurrent disease. Prion diagnosis was confirmed
by histopathological assessment of vacuolation in the brain. For the con-
struction of lesion profiles, vacuolar changes were scored in nine distinct
gray matter and three distinct white matter areas of the brain as described
previously (28).
Oral T. muris infection. Trichuris muris was maintained as described
previously (29). Mice were infected orally by gavage with200 infective
eggs. Some mice were killed at 14 days postinfection, and the worm bur-
den (164 22; n 4) was assessed as described previously (30).
Immunohistochemisty (IHC) and immunofluorescent analyses.
Whole-mount immunostaining was performed as previously described
(16). Briefly, 4-cm pieces of intestine were washed in phosphate-buff-
ered saline (PBS) prior to incubation in Hanks’ balanced salt solution
(HBSS) containing 5 mM EDTA (both from Life Technologies, Paisley,
United Kingdom) in a shaking incubator at 37°C. The epithelium was
subsequently washed off, and the intestinal pieces were fixed in 10% for-
mal saline (Cellpath, Powys, United Kingdom), washed in Tris-buffered
saline containing 0.1% Triton X-100 (Sigma, Poole, United Kingdom)
(TBST), and nonspecific binding blocked with 2.5% normal goat serum
(Jackson ImmunoResearch, Newmarket, United Kingdom). Intestinal
pieces were then stained with rat anti-mouse CD35monoclonal antibody
(MAb; clone 8C12; BD Biosciences) to detect FDC and rat anti-mouse
B220 MAb (clone RA3-6B2; Life Technologies) to detect B cells.
Portions of intestine were also removed and snap-frozen at the tem-
perature of liquid nitrogen. Serial frozen sections (10 m in thickness)
were cut on a cryostat and immunostained with antibodies as follows:
FDC were visualized by staining with anti-CD35 MAb; cellular PrPC was
detected using PrP-specific polyclonal antibody (pAb) 1B3 (31); B cells
were detected using rat anti-mouse B220 MAb; M cells were detected
using rat anti-mouse GP2 MAb (MBL International, Woburn, MA);
mononuclear phagocytes were detected using rat anti-mouse CD11b an-
tibody (cloneM1/70; eBioscience,Hatfield,UnitedKingdom).Nerve syn-
apses were detected using rabbit anti-synaptophysin 1 (Synaptic Systems,
Göttingen, Germany). When appropriate, sections were counterstained
with 4=,6-diamidino-2-phenylindole (DAPI; Life Technologies).
For the detection of disease-specific PrP (PrPd) in intestines, MLN,
spleens, and brains, tissues were fixed in periodate-lysine-paraformalde-
hyde fixative and embedded in paraffin wax. Sections (thickness, 6 m)
were deparaffinized and pretreated to enhance the detection of PrPd by
hydrated autoclaving (15min, 121°C, hydration) and subsequent immer-
sion in formic acid (98%) for 5 min. Sections were then immunostained
with 1B3 PrP-specific pAb. For the detection of astrocytes, brain sections
were immunostained with anti-glial fibrillary acidic protein (GFAP;
Dako, Ely, United Kingdom). For the detection of microglia, deparaf-
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finized brain sections were first pretreated with Target Retrieval Solution
(Dako) and subsequently immunostained with anti-ionized calcium-
binding adaptor molecule 1 (Iba-1; Wako Chemicals GmbH, Neuss, Ger-
many). For the detection of FDC in intestines, MLN, and spleens, depar-
affinized sections were first pretreated with Target Retrieval Solution
(Dako) and subsequently immunostainedwith anti-CD21/35 (clone 7G6;
BD Biosciences). Paraffin-embedded tissue (PET) immunoblot analysis
was used to confirm the PrPd detected by immunohistochemistry with
proteinase K (PK)-resistant PrPSc (32). Membranes were subsequently
immunostained with 1B3 PrP-specific pAb.
For light microscopy, following the addition of primary antibodies,
biotin-conjugated species-specific secondary antibodies (Stratech, So-
ham, United Kingdom) were applied, and immunolabeling was revealed
using horseradish peroxidase (HRP) conjugated to the avidin-biotin
complex (ABC kit; Vector Laboratories, Peterborough, United Kingdom)
and visualized with 3,3=-diaminobenzidine (DAB; Sigma). Sections were
counterstained with hematoxylin to distinguish cell nuclei. For fluores-
cence microscopy, following the addition of primary antibody, streptavi-
din-conjugated or species-specific secondary antibodies coupled to Alexa
Fluor 488 (green), Alexa Fluor 594 (red), or Alexa Fluor 647 (blue) dyes
(Life Technologies) were used. Sections were counterstained with either
DAPI or Alexa Fluor 647-conjugated phalloidin (Life Technologies) and
subsequently mounted in fluorescent mounting medium (Dako).
Whole-mount immunostained intestinal pieces were visualized on a
Nikon EC1 confocal microscope (Nikon, Kingston upon Thames, United
Kingdom). ILF andmature ILF were enumerated visually along the entire
length of the intestinal piece. Images of cryosections were obtained using
a Zeiss LSM7 confocal microscope (Zeiss, Welwyn Garden City, United
Kingdom).
Oral gavage with fluorescent microbeads. Mice were given a single
oral gavage of 2  1011 Fluoresbrite Yellow Green-labeled 200-nm mi-
crobeads (Polysciences, Eppelheim, Germany) in 200 l PBS. Mice were
culled 24 h later, and Peyer’s patches, SI segments, cecum, and colon were
snap-frozen at the temperature of liquid nitrogen. Serial frozen sections
(10 m in thickness) were cut on a cryostat and counterstained with
DAPI. Images of follicles from three Peyer’s patches per mouse (n  4
mice), cecal patches (1 patch permouse, n 3mice), and colonic patches
(1 or 2 patches per mouse, n 3 mice) from 4 nonsequential sections (at
least 100 m apart) were acquired using a Nikon Eclipse E400 fluores-
cence microscope using Micro Manager (http://www.micro-manager
.org). Images were acquired for every ILF in nonsequential sections (at
least 100 m apart) of SI (16 sections per mouse, n 4 mice), cecum (4
sections per mouse, n 4 mice), and colon (8 sections per mouse, n 4
mice). The number of beads and the area of lymphoid tissue in each
section were determined using ImageJ (http://imagej.nih.gov/ij), and the
bead density was calculated. Tissue autofluorescence was subtracted from
displayed images using ImageJ.
Statistical analyses. Data are presented as means  standard errors
(SE). Unless indicated otherwise, significant differences between samples
in different groups were sought by Student’s t test. In instances where
there was evidence of nonnormality, data were analyzed by nonparamet-
ric analysis of variance (ANOVA) (Kruskal-Wallis test) with Dunn’s mul-
tiple comparison post hoc test. P values of0.05 were accepted as signif-
icant.
RESULTS
Mice with FDC-containing GALT predominantly in the large
intestine. To study the relative contributions of the GALT in the
SI and LI to oral prion disease pathogenesis, we first created mice
in which the FDC-containing GALT was found predominantly in
the LI at the time of exposure. Initially, the GALT in the SI and LI
of adult C57BL/6J mice were characterized by whole-mount im-
munostaining of entire intestines to detect the presence of B-cell
follicles (CD45R/B220	 cells; green) and FDC networks (CD35	
cells; red) (16). The aim here was to determine the status of the LI
GALT and whether it was potentially capable of supporting prion
uptake and accumulation. The SI typically contained 5 to 7 mul-
tifollicular Peyer’s patches and numerous isolated lymphoid folli-
cles (ILF) (Fig. 1A). ILF can be classified as either immature ILF
(primary B-cell follicles) or mature ILF containing a single orga-
nized B-cell-containing germinal center, an FDC network, and an
overlying M-cell-containing follicle-associated epithelium (FAE)
(12–16, 33). In the SI of adult C57BL/6J mice, the ILF were almost
entirely immature and lacked FDC networks (Fig. 1A and B). In
the LI, a number of multifollicular patch-like structures and ILF
were also identified (Fig. 1A). However, a significantly higher
number of the ILF within the LI were mature and contained FDC
networks than within the SI (Fig. 1A and B; P 0.0116).
The transcytosis of prions across the intestinal epitheliumbyM
cells and their subsequent replication upon PrPC-expressing FDC
are obligatory for efficient neuroinvasion after oral exposure (3, 5,
27, 34). Immunohistochemical (IHC) analysis confirmed that the
mature ILF in the LI contained PrPC-expressing FDC networks
(Fig. 1C, arrow) and glycoprotein 2-expressing mature M cells
within the overlying epithelium (Fig. 1D, arrows) (35). Further-
more, the density and distribution of the enteric innervation as-
sociated with the GALT in the SI and LI appeared to be similar
(Fig. 1E) (36). These data suggest that theGALT in the LI also have
the potential to be important sites of prion accumulation and
neuroinvasion.
Themultifollicular Peyer’s patches in the SI and their counter-
parts in the LI (cecal and colonic patches) are dependent on lym-
photoxin  receptor (LTR) signaling during embryogenesis for
formation and are absent in LT-deficientmice (37) ormice treated
with LTR-Ig in utero (25). ILF formation is also LTRdependent
(3, 12, 14, 16). However, unlike Peyer’s patches and their patch-
like counterparts in the LI, ILF formation occurs postnatally and
their development from cryptopatches in the intestines of LT-
deficient mice can be induced by reconstitution with LT-express-
ing (wild-type) hematopoietic cells (3, 12–14, 16, 38). Although in
utero an LTR-signaling blockade prevents the development of
Peyer’s, cecal, and colonic patches, the postnatal development
of ILF throughout the SI and LI is conserved, with higher num-
bers of ILF observed due to the absence of other GALT (14, 15).
The postnatal formation and maturation of ILF in the LI oc-
curs at a significantly earlier time after birth than in the SI (15).
Therefore, by exploiting these differing developmental kinetics,
mice with FDC-containing GALT predominantly in the LI could
be generated. ILF development in the SI and that in the LI of in
utero LTR-Ig-treated mice (termed “LTR-Ig-treated mice”
hereinafter) were compared to establish the optimal time when
FDC-containing GALT (mature ILF) were present only in the LI.
Pregnant C57BL/6J mice were injected i.v. with LTR-Ig (24) (or
hu-IgG as a control) on day E11.5 to block Peyer’s, cecal, and
colonic patch development in the progeny and induce the devel-
opment of higher numbers of ILF (12, 14, 15, 25). At intervals after
birth, entire intestines were whole-mount immunostained to de-
tect B-cell follicles (CD45R/B220	 cells; green) andFDCnetworks
(CD35	 cells; red) (16). Our analysis showed that the LI of 21-
day-old LITR-Ig-treated mice contained significantly more ILF
than the SI (Fig. 2A). Furthermore,many of these ILFweremature
and contained FDC networks (Fig. 2B). In the SI of LTR-Ig-
treatedmice at this time, few if anymature ILF were detected (Fig.
2B). These data clearly show that in the intestines of 21-day-old
LTR-Ig-treated mice the predominant FDC-containing GALT
Donaldson et al.
9534 jvi.asm.org September 2015 Volume 89 Number 18Journal of Virology
 o
n
 O
ctober 14, 2015 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
were the mature ILF in the LI (Fig. 2C) (hereinafter termed “mice
with FDC-containing GALT only in the LI”). In contrast, by 56
days after birth, many FDC-containing mature ILF were distrib-
uted throughout the SI and LI (termed “mice with FDC-contain-
ing GALT throughout the SI and LI” hereinafter). Thus, by expos-
ing LTR-Ig-treatedmice to prions at 21 or 56 days after birth, we
could determine whether FDC-containing GALT in the SI or the
LI were important sites of prion accumulation and neuroinvasion
after oral exposure.
TheGALT in the LI are not early sites of prion accumulation
after oral exposure. Next, we determined where the important
sites of prion accumulation were after oral exposure. If the SI was
FIG 1 GALT status in the small and large intestines. (A)Whole-mount IHC analysis of the GALT in the intestines of adult C57BL/6J mice. Intestinal pieces were
whole-mount immunostained to detect B-cell follicles (CD45R/B220	 cells; green) and FDCnetworks (CD35	 cells; red). In the small intestine (SI) the ILFwere
mostly immature (iILF) and lacked FDC networks (white arrows). In the large intestine (LI), many of the ILF were mature (mILF) and contained FDC networks
(yellow arrows). (B) Determination of ILF and mILF density in the SI and LI of adult C57BL/6J mice (open bars and closed bars, respectively). Data are derived
from the whole intestines and are presented as the mean number of GALT structures/cm2 (n  4 mice/group). (C) IHC detection of PrPC-expressing FDC
networks in LI mILF. Cryosections of colon were immunostained to detect FDC (CD35	 cells; red), PrPC (blue), and B cells (CD45R/B220; green). (D) The
follicle-associated epithelia (FAE) overlying ILF in the LI contain glycoprotein 2-expressing mature M cells (GP2; red). Cryosections were counterstained to
detect B cells (CD45R/B220; green) and cell nuclei (DAPI; blue). The boxed area in the left-hand panel is presented at higher magnification in the right-hand
panel. (E) Comparison of the innervation associated with the GALT in the SI and LI. Sections of intestines were immunostained to detect nerve synapses
(synaptophysin 1; red), B-cell follicles (CD45R/B220	 cells; green), and cell nuclei (DAPI; blue).
Oral Prion Pathogenesis and the GALT
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the major site, we hypothesized that the specific absence of FDC-
containing GALT in the SI at the time of exposure (LTR-Ig-
treated mice exposed to prions at 21 days after birth) would block
neuroinvasion from the intestine. Additionally, disease pathogen-
esis would be unaffected in LTR-Ig-treated mice exposed to pri-
ons at 56 days after birth (which contain mature ILF in the SI and
LI) compared to controls. Conversely, if the LI played an impor-
tant role, prion pathogenesis would be unaffected in mice with
FDC-containing GALT restricted to the LI at the time of exposure
(LTR-Ig-treated mice exposed to prions at 21 days after birth).
Pregnant C57BL/6J mice were injected i.v. with LTR-Ig (or
hu-IgG as a control) on day E11.5 to block Peyer’s, cecal, and
colonic patch development in the progeny and induce the devel-
opment of higher numbers of mature ILF. At either 21 days (LI
FDC-containing GALT only) or 56 days (SI and LI FDC-contain-
ing GALT) after birth, mice were orally exposed to ME7 scrapie
prions. The GALT status in the intestines of each treatment and
control group used in this study at the time of oral prion exposure
is described in Table 1. Both PET immunoblot (32) and IHCwere
used to detect disease-specific PrP accumulations characteristi-
FIG 2 GALT status in the small and large intestines of in utero LTR-Ig-treated mice. (A, B) C57BL/6J mice were treated in uterowith LTR-Ig on day E11.5 to
block Peyer’s, cecal, and colonic patch development and induce the development of higher numbers of ILF. At intervals after birth, entire intestines were
whole-mount immunostained to detect B-cell follicles and FDC networks. Mice were culled at intervals after birth, and the total ILF (A) and mILF (B) in the SI
and LI (closed and open symbols, respectively) were counted; n 4mice/group; *, P 0.01; **, P 0.001; ***, P 0.0001. (C)Whole-mount immunostaining
of ILF status (CD45R/B220	 cells, green; CD35	 cells, red) in the intestines of 21-day-old (upper panels) and 56-day-old (lower panels) control Ig- and
LTR-Ig-treated mice (n 4 mice/group).
TABLE 1 GALT status in the intestines of each experimental group at the time of oral prion exposure
Treatmenta
Age of mice
(days)
Small intestine GALT status Large intestine GALT status
Peyer’s
patches
Density of
immature ILFb
Density of
mature ILF
Cecal and
colonic patches
Density of
immature ILF
Density of
mature ILF
Control IgG 21 Present 0 0 0 0 Present 2 0 1 0
LTR-Ig 21 Absent 1 0 0 0 Absent 3 0 2 0
Control IgG 56 Present 5 1 0 0 Present 3 0 1 0
LTR-Ig 56 Absent 17 4 5 1 Absent 6 1 3 0
a Pregnant mice were injected i.v. with LTR-Ig on day E11.5 or with control IgG. Progeny mice were analyzed at the ages indicated.
b Entire SI and LI were whole-mount immunostained to detect the presence of B-cell follicles (CD45R/B220	 cells) and FDC networks (CD35	 cells), and the number and status of
ILF were recorded. Density values are mean numbers of ILF/cm2 SE; n 4 mice/group.
Donaldson et al.
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cally found only in prion-affected tissues and considered a reliable
biochemical marker for the presence of infectious prions (3, 5, 26,
27). PET immunoblot analysis detects prion disease-specific, rel-
atively proteinaseK (PK)-resistant PrPSc.However, as PKdestroys
tissue microarchitecture, disease-specific abnormal accumula-
tions of PrP (PrPd) were detected by IHC (3, 27, 34).
In the SI of all control IgG-treated mice, heavy PrPd accumu-
lations were detected in the Peyer’s patches at 15 weeks after oral
prion exposure, consistent with localization upon CD21/35-ex-
pressing FDC (Fig. 3A and C, arrows). PET immunoblot of adja-
cent sections confirmed the presence of high levels of prion-spe-
cific PrPSc in Peyer’s patches from control IgG-treated mice (Fig.
3A and C). However, PrPd was undetectable in colonic patches
(Fig. 3A and C) or in immature ILF throughout the SI and the
immature ILF and occasional mature ILF in the LI (Fig. 3B and D,
upper panels). In mice with only LI FDC-containing GALT at the
time of exposure (LTR-Ig-treated mice exposed to prions at 21
days after birth), no PrPSc was detected in themature ILF in the LI
or the ILF in the SI (Fig. 3B, lower panels). However, in the intes-
tines of mice with abundant FDC-containing mature ILF
throughout the SI and LI at the time of oral prion exposure
(LTR-Ig-treated mice exposed to prions at 56 days after birth),
heavy PrPSc accumulations were detected in the mature ILF in the
SI but not in those in the LI (Fig. 3D, lower panels).
After oral exposure, prions first accumulate in the GALT be-
fore spreading to other lymphoid tissues, including the MLN and
FIG 3 FDC-containing GALT in the large intestine are not early sites of prion accumulation after oral exposure. C57BL/6J mice were treated in utero with
LTR-Ig on day E11.5 to block Peyer’s, cecal, and colonic patch development and induce the development of higher numbers of ILF. Control mice were treated
with hu-Ig. At 21 (A and B) or 56 (C and D) days old (d.o.), mice were orally exposed to ME7 scrapie prions, and entire intestines were collected 105 days after
exposure. (A andC)High levels of PrPd (brown)were detected in associationwith FDC (CD21/35-positive cells; brown) in the Peyer’s patches in the SI of control
mice (arrows). Analysis of adjacent sections by PET immunoblot analysis confirmed the presence of PK-resistant PrPSc (blue/black). In contrast, no PrPd or PrPSc
was detected the in colonic patches in the LI of the same controlmice. (B) Inmicewith FDC-containingGALT (mature ILF) only in the LI at the time of oral prion
exposure (21-d.o. LTR-Ig-treatedmice), PrPd/PrPSc accumulation in theGALTwas blocked. (D) In contrast, inmicewith FDC-containingGALT (mature ILF)
throughout the SI and LI at the time of oral prion exposure (56-d.o. LTR-Ig-treated mice), high levels of PrPd and PrPSc were detected in association with FDC
(CD21/35-positive cells) in themature ILF in the SI (arrows) but were undetectable in the LI. Sections were counterstained with hematoxylin to detect cell nuclei
(blue). For all panels, there were 4 mice/group.
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spleen (3, 5, 26). Here, by 15 weeks after oral prion exposure,
heavy PrPSc accumulations were also detectable upon FDC in the
MLNand spleen of control IgG-treatedmice (Fig. 4A andB, upper
panels) (26, 27). In contrast, in mice with FDC-containing GALT
only in the LI at the time of exposure (LTR-Ig-treated mice ex-
posed to prions at 21 days after birth), the subsequent spread of
prions to the MLN and spleen was impeded (Fig. 4A, lower pan-
els). However, high levels of PrPSc were detected upon FDC in the
MLN and spleen of mice with FDC-containing mature ILF
throughout the SI and LI at the time of oral exposure (LTR-Ig-
treated mice exposed to prions at 56 days after birth) (Fig. 4B,
lower panels).
These data clearly show that the GALT in the SI are the major
early sites of prion accumulation after oral exposure. Further-
more, in the specific absence of FDC-containing GALT in the SI,
the subsequent dissemination of prions from the GALT to other
lymphoid tissues is impeded.
The GALT in the SI, not the LI, are important sites of prion
neuroinvasion after oral exposure. Efficient neuroinvasion fol-
lowing oral exposure of mice to prions is dependent upon FDC-
containing GALT (3–5), but whether this occurs via the SI or LI
GALT is uncertain. We next compared the influence of SI and LI
GALT on neuroinvasion and disease susceptibility. Consistent
with the high levels of early PrPSc accumulation upon FDCwithin
the GALT (Fig. 3C and D), mice with mature ILF throughout the
SI and LI at the time of oral exposure (56-day-old LTR-Ig-
TABLE 2 Influence of the large intestine GALT on oral prion disease susceptibility
Treatmenta
Presence of FDC in GALT
at time of exposureb
No. of animals showing PrPSc
accumulation in GALT/total no.
Mean incubation period
(days SE)c
Incidence of:
Clinical
diseased
Histopathological signs of
prion disease in the braine
Control IgG PP, SI-ILF, CP, LI-ILF 8/8 387 17 8/8 8/8
LTR-Ig LI-ILF only 2/9 323, 344, 7 X
 518 2/9 2/9
a Pregnant mice were injected i.v. with LTR-Ig or control IgG, and the progeny mice were orally exposed to ME7 scrapie prions when 21 days old.
b PP, Peyer’s patches; SI-ILF, small intestine isolated lymphoid follicles; CP, cecal and colonic patches; LI-ILF, large intestine isolated lymphoid follicles.
c The notation “n X
 518” means that mice were free of the clinical and pathological signs of prion disease up to at least this duration after oral exposure. Boldface values represent
individual incubation periods for individual clinically and pathologically prion disease-positive mice.
d No. of animals displaying clinical signs of prion disease/no. of animals tested.
e No. of animals with histopathological signs of prion disease in the brain (vacuolation in the neuropil and PrPSc accumulation)/no. of animals tested.
FIG 4 In the absence of FDC-containing GALT in the SI at the time of oral prion exposure, the accumulation of PrPSc in the MLN and spleen is impeded.
C57BL/6J mice were treated in utero with LTR-Ig on day E11.5 to block Peyer’s, cecal, and colonic patch development and induce the development of higher
numbers of ILF. Controlmicewere also treatedwith hu-Ig. At 21 (A) or 56 (B) days old (d.o.),micewere orally exposed toME7 scrapie prions, and themesenteric
lymph nodes (MLN) and spleen were collected 105 days after exposure. (A) High levels of PrPd were detected in association with FDC (CD21/3-positive cells;
brown) in the MLN and spleens of control mice (upper panels; arrows). Analysis of adjacent sections by PET immunoblot analysis confirmed the presence of
PK-resistant PrPSc (blue-black; arrows). In contrast, in the absence of FDC-containing GALT in the SI at the time of oral prion exposure, the accumulation of
PrPd and PrPSc in the inMLN and spleen was blocked (lower panels). (B) However, in mice with FDC-containing GALT throughout the SI and LI at the time
of oral prion exposure, high levels of PrPd and PrPSc were detected in association with FDC in the MLN and spleen (lower panels; arrows). Sections were
counterstained with hematoxylin to detect cell nuclei (blue). For all panels, there were 4 mice/group.
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treatedmice) succumbed to clinical prion disease at the same time
as control mice (322  2 and 321  7 days, respectively; n 
6/group). However, whereas all control mice orally exposed to
prions at 21 days old succumbed to clinical prion disease, those
with LI FDC-containing GALT only at the time of exposure dis-
played dramatically reduced disease susceptibility (21-day-old
LTR-Ig-treatedmice). Seven of nine of these mice remained free
of clinical signs of prion disease518 days after oral exposure, at
which time the experiment was terminated (Table 2). Character-
istic spongiform pathology, astrogliosis, microgliosis, and PrPSc
accumulation typically associated with terminal infection with
ME7 scrapie prions were detected in the brains of all clinically
affected mice (Fig. 5A and B). In contrast, no histopathological
signs of prion disease were detected within the brains of any of the
clinically negative mice (Fig. 5A and B).
At the terminal stage of disease, high levels of PrPSc weremain-
tained upon FDC in the SI GALT and spleen of all control mice
(Fig. 5C). Furthermore, at the terminal stage of disease in control-
treated mice, heavy PrPSc accumulations were now also detected
upon FDC within the ILF in the LI (Fig. 5C, upper left-hand pan-
els, arrows). However, in mice with FDC-containing GALT only
in the LI at the time of prion exposure, no evidence of PrPSc accu-
mulation within their GALT and spleens was observed (Fig. 5C,
lower panels), implying that disease pathogenesis had been im-
peded. These data clearly show that in the specific absence of FDC-
containing GALT in the SI, prion neuroinvasion following oral
exposure is substantially impaired, demonstrating that SI FDC-
containing GALT are the important early sites of prion accumu-
lation or neuroinvasion after oral exposure.
Effect of congruent Trichuris muris infection on oral prion
pathogenesis. We next determined whether pathology restricted
to the LI may influence oral prion disease pathogenesis. For ex-
ample, pathology to the LI mucosa may enhance disease patho-
genesis by increasing prion uptake across the intestinal epithe-
lium. Conversely, it is plausible that lymphocytes and
macrophages infiltrating the lamina propriamay decrease suscep-
tibility due to prion sequestration (34, 39). These pathological
characteristics are observed in the LI during murine Trichuris
muris infection, a well-characterized natural mouse model of T.
trichiura, one of the most prevalent human helminth infections
worldwide. T. muris infection is restricted to the LI, where it bur-
rows within the epithelium (29) (Fig. 6A). Peak expulsion coin-
cides with the influx of large numbers of macrophages (CD11b	
and CD68	 cells) into the lamina propria of the LI (40) (Fig. 6B).
T. muris infection also stimulates the development of ILF in the LI
(40) (Fig. 6C). This parasite has distinct advantages for use in this
study as the infection does not affect the SI (Fig. 6).T.muris is also
a natural mouse pathogen and does not require antibiotic treat-
ment or fasting to establish infection, which may influence oral
prion disease pathogenesis.
Groups of mice were orally infected with200 T. muris infec-
tive eggs and subsequently orally exposed toME7 scrapie prions at
the following specific intervals after T. muris infection to deter-
mine whether the parasite-induced pathology in the LI may influ-
ence prion disease pathogenesis: (i) day 0,mice were exposed toT.
muris and prions at the same time; (ii) day 7, T. muris infection
was established in the LI, coincident with the intracellular pres-
ence of the first larval stage of the parasite within an epithelial
syncytium (Fig. 6A); (iii) day 21, time of peak T. muris clearance,
coincident with the influx ofmacrophages into the lamina propria
(Fig. 6B), and the subsequent significant increase in the number of
ILF in the LI by day 28 (40, 41) (Fig. 6C); (iv) day 42, approxi-
mately 7 days after clearance of T. muris. An additional group of
mice were orally exposed toME7 scrapie prions alone as a control.
Irrespective of the time at which mice were coexposed with
prions, all mice succumbed to clinical prion disease with incuba-
tion periods similar to those of mice exposed to prions alone (Ta-
ble 3). Congruent T. muris infection also did not influence the
severity and distribution of the histopathological signs of prion
disease in the brains of any of the clinically affected mice (Fig. 7A
and B).However, at 15weeks after oral prion exposure, high levels
of PrPSc were detectable in the LI of mice with congruent T. muris
infection, in contrast to mice exposed to prions alone (Fig. 7C).
These data clearly show that pathology specifically restricted to the
LI, such as that which occurs during T. muris infection, does not
affect the onset or severity of oral prion disease but can facilitate
the earlier accumulation of prions within LI GALT.
Large intestinal GALT is relatively deficient in the uptake of
orally administered particulate antigen. The absence of prion
accumulation in the LI GALT at early time points contrasted with
that observed at later stages of disease and suggested that the LI
GALT does not efficiently uptake orally acquired prions from the
gut lumen. While the epithelia covering both the SI and the LI
GALT have M cells (Fig. 1D) (27), region-specific differences in
factors such asmucus thickness (42)may play a role in preventing
prion uptake in the LI. It was unclear whether reduced uptake in
the LI was specific to prions or whether the uptake of other orally
administered particulate antigens was similarly reduced. Mi-
crobeads are commonly used to assessM-cell uptake of particulate
antigens and after administration are readily detected within or
below M-cell-rich areas overlying GALT, but not within the vil-
lous epithelium and the underlying lamina propria (27, 33, 43).
FIG 5 Prion neuroinvasion is impeded in the absence of FDC-containing GALT in the SI at the time of oral exposure. (A) High levels of spongiform pathology
(H&E, upper row), heavy accumulations of PrPd (brown, second row) and disease-specific PrPSc (blue-black, third row), reactive astrocytes expressing GFAP
(brown, third row) and activemicroglia expressing Iba-1 (brown, bottom row) were detected in the brains of all orally exposed clinically scrapie-affected control
IgG-treatedmice (left-hand panels; n 8). However, most of themice with FDC-containing GALT only in the LI at the time of exposure (LTR-Ig-treatedmice
exposed to prions at 21 days old, right-hand panels, n 7/9) remained free of the clinical and histopathological signs of prion disease up to at least 518 days after
oral exposure. Clin., clinical prion disease status; pos., positive; neg., negative. The insets in the upperH&Epanels show a representative area from the same image
at higher magnification. (B) The severity and distribution of the spongiform pathology (vacuolation) within each brain were scored on a scale of 1 to 5 in nine
graymatter and three white matter areas: G1, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus;
G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and adjacent motor cortex; W1, inferior and middle cerebellar peduncles; W2,
decussation of superior cerebellar peduncles; andW3, cerebellar peduncles. Each point represents the mean vacuolation score SE. (C) At the clinical stage of
disease, high levels of PrPd (brown) were detected in association with FDC in the ILF in the LI and the spleens of control mice (upper panels; arrows). Analysis
of adjacent sections by PET immunoblot analysis confirmed the presence of PK-resistant PrPSc (blue-black; arrows). In contrast, in the absence of FDC-
containing GALT in the SI at the time of oral prion exposure, the accumulation of PrPd and PrPSc in the GALT in the LI and spleen was blocked (lower panels).
Sections were counterstained with hematoxylin to detect cell nuclei (blue). Data are representative of tissues from 8 or 9 mice/group.
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FIG 6 Infection with the nematode parasiteTrichuris muris is restricted to the cecum. Groups ofmice were orally infected with200T.muris infective eggs, and
tissues were collected at intervals after exposure. (A) T. muris establishes infection in the cecal epithelium. Left-hand panels show autofluorescent immature
worms adhered to the cecal epithelium. Clusters of B-cell follicles (ILF, CD45R/B220	 cells, green) are indicated (arrowheads). The right-hand panel (H&E)
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We therefore considered thesemicrobeads a goodmodel for prion
uptake in the intestine, as both are transported byM cells and lack
any means of self-propulsion. Additionally, the use of fluores-
cently labeled microbeads enables them to be readily tracked his-
tologically, which would not be possible following oral exposure
to a physiologically relevant (low) dose of fluorescently labeled
prions.
To determine if microbeads were acquired by both SI and LI
GALT, C57BL/6J mice (not treated in utero with LTR-Ig) were
orally gavaged with 2 1011 200-nm fluorescent microbeads, and
24 h later, the presence of microbeads in cryosections of Peyer’s,
cecal, and colonic patches was analyzed. While microbeads were
readily observable in Peyer’s patches in the SI, significantly fewer
were observed in the cecal patches in LI, despite numerous mi-
crobeads in the lumen (Fig. 8A and B). The presence of mi-
crobeads within colonic patches was rare. A similar pattern was
observed in ILF, with much higher densities of microbeads ob-
served in SI ILF than in those in the LI (Fig. 8C andD), despite the
increased ILF maturity (associated with the development of an
M-cell-containing FAE) observed in the colon (Fig. 1B and D).
Therefore, orally administered, nonmotile particulate antigens,
such as prions, are preferentially taken up into SI GALT and rarely
acquired by the LI GALT.
DISCUSSION
Here we show that the SI GALT are the major early sites of prion
accumulation and neuroinvasion after oral exposure. In the ab-
sence of SI FDC-containing GALT at the time of oral exposure,
prions failed to accumulate in the remaining FDC-containing
GALT in the LI, dramatically reducing disease susceptibility and
rendering the mice refractory to infection. Oral prion disease
pathogenesis in natural hosts shows temporal characteristics sim-
ilar to those observed in the current study (21–23), suggesting that
the SI GALT are also the major early sites of prion accumulation
and neuroinvasion during natural prion infections. Congruent
infection with the LI-restricted pathogen T. muris did facilitate
earlier prion accumulation in LIGALT, but ultimately this and the
presence of significant LI pathology around the time of prion ex-
posure did not influence prion neuroinvasion, underlining the
important role of the SIGALT in this process. Together, these data
demonstrate that the FDC-containing GALT in the SI, specifically
Peyer’s patches and mature ILF, are the major early sites of prion
accumulation and neuroinvasion after oral exposure.
Our data show that Peyer’s patches andmature ILF in the SI are
each individually capable of supporting prion accumulation and
neuroinvasion. The only FDC-containing GALT in the SI of the
21-day-old control IgG-treated and 56-day-old LTR-Ig-treated
mice were Peyer’s patches and mature ILF, respectively, and both
were fully susceptible to oral prion infection. In the absence of
FDC-containing GALT in the SI, the gastrointestinal tract appears
to act as a barrier against oral prion infection. Unfortunately, it is
not currently possible to create mice with FDC-containing GALT
exclusively in the SI.
Prions are acquired from the gut lumen viaM cells (27, 44, 45),
specialized epithelial cells that transcytose luminal antigens (46).
Although M cells are abundant in SI Peyer’s patches, they are less
numerous in cecal patches (47). Our data show that LI GALT are
also much less efficient at transcytosing luminal antigens. The LI
epithelium is also coveredwith a thick layer ofmucus (42). Both of
these factors likely contribute to the inability of LI GALT to ac-
quire sufficient quantities of prions to establish infection.Without
SI FDC-containing GALT, the gastrointestinal tract acts as a bar-
rier against prion infection. While some prions may be delivered
to the MLN (48, 49), the presence of the MLN in mice lacking SI
GALT did not influence susceptibility, implying that the levels of
prions delivered to MLN immediately after oral exposure are in-
sufficient to establish replication. It has been suggested that prions
are transcytosed into cecal patches byM cells (50), contrasting the
absence of accumulation observed in this study. This discrepancy
most likely relates to differing doses of prions (100 times greater
than used here) and methods of administration used (gavage
rather than feeding), potentially facilitating the uptake of a large
shows the close association ofT.muriswith the cecal epithelium/lamina propria (arrows) and sites of damage to the gut epithelium. Tissues were analyzed on day
14 (left-hand andmiddle panels) and day 7 (right-hand panel) postinfection withT.muris. (B)T.muris infection stimulates the influx ofmacrophages (CD11b	
cells, green, upper andmiddle panels; CD68	 cells, green, lower panels) into the lamina propria of the cecum, but not in the SI. (C) The distal 8 cm of ileum and
the entire cecumwere whole-mount immunostained to detect B cell follicles (B220	 cells; green).T.muris infection stimulates the development of abundant ILF
(arrows) in cecumbut not the SI. The histogram shows that the number of ILF in the cecumofT.muris-infectedmice was significantly greater than that observed
in controls. Tissues were analyzed on day 28 postinfection with T. muris. Data in all panels are derived from analysis of tissues from 4 mice/group.
TABLE 3 Effect of congruent Trichuris muris infection on oral prion disease pathogenesis
Mouse treatment
Characteristic T. muris-mediated
pathology in LI mucosa
Mean prion disease incubation
period (days SE)
Incidence of:
Clinical
diseaseb
Histopathological signs of
prion disease in the brainc
Prions alone None 343 9 8/8 8/8
T. muris infection, followed
by prions at daya:
0 None 350 7 7/7 7/7
	7 Syncytial tunnels in epithelium 356 12 7/7 7/7
	21 Influx of intraepithelial macrophages 356 13 8/8 8/8
	42 7 days after expulsion of T. muris 347 4 7/7 7/7
a Mice were orally infected with T. muris and then were orally exposed to ME7 scrapie prions after the indicated number of days.
b No. of animals displaying clinical signs of prion disease/no. of animals tested.
c No. of animals with histopathological signs of prion disease in the brain (vacuolation in the neuropil and PrPSc accumulation)/no. of animals tested.
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bolus of prions into additional GALT compartments, which does
not occur following exposure to a physiologically relevant dose via
the oral cavity.
Following peripheral exposure, prions accumulate first in the
draining lymphoid tissue (such as Peyer’s patches in the SI after
oral exposure) and subsequently spread to most other lymphoid
tissues, including nondraining lymph nodes and spleen (3, 5, 26,
51). B cells recirculate between lymphoid tissues for several weeks
(52) and often acquire FDC surface proteins during cognate anti-
gen capture (53). We have shown that B cells recirculating be-
tween lymphoid tissues play an important role in the initial trans-
fer of prions from the draining lymphoid tissue to other
nondraining lymphoid tissues (51). The detection of PrPSc within
LI GALT only at much later stages of disease is entirely consistent
with secondary dissemination by B cells from the initial sites of
infection in the GALT of the SI. The preferential migration of
Peyer’s patch-derived IgA-secreting plasmablasts to the SI,
rather than to the LI (54), may enhance prion accumulation in
FIG 7 Congruent T. muris infection did not influence the severity and distribution of the histopathological signs of prion disease in the brains of clinically
affected mice. Groups of mice were orally infected with 200 T. muris infective eggs and subsequently orally exposed to prions on the days (d) indicated in
relation to the ongoingT.muris infection in the large intestine. (A) Brainswere collected fromallmicewith clinical prion disease, and the neuropathological signs
of prion disease were compared. High levels of spongiform pathology (H&E, upper row), heavy accumulations of PrPd (brown, second row), reactive astrocytes
expressingGFAP (brown, third row), and activemicroglia expressing Iba-1 (brown, bottom row)were detected in the brains of all clinically scrapie-affectedmice.
The insets in the upper H&E panels show a representative area from the same image at highermagnification. (B) The severity and distribution of the spongiform
pathology (vacuolation) within each brain were scored on a scale of 1 to 5 in nine gray matter and three white matter areas: G1, dorsal medulla; G2, cerebellar
cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and
adjacentmotor cortex;W1, inferior andmiddle cerebellar peduncles;W2, decussation of superior cerebellar peduncles; andW3, cerebellar peduncles. Each point
represents themean vacuolation score SE. Data are representative of tissues from 7 or 8mice/group. (C) At 105 days after oral prion infection, no PrPd or PrPSc
was detected the in cecal patches in the LI of mice orally exposed to prions alone (upper panels). In contrast, high levels of PrPd and PrPSc were detected in the
cecal patches of prion-infectedmice with congruent T. muris infection (lower panels, arrows). Representative images are frommice exposed to prions at 21 days
after T. muris infection. Data are representative of tissues from 4 mice/group.
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the SI and restrict the early secondary dissemination to LI
GALT.
After accumulating upon FDC, the prions are then amplified
above the threshold required for neuroinvasion (3–5, 9, 55) and
spread to the enteric nervous system and the CNS, ultimately
causing neurodegeneration and death (9–11). Infection can
spread to enteric nerves in SI GALT within 21 days of exposure
(9), potentially in associationwith classical dendritic cells (56, 57).
In the current study, no PrPSc was detected in the LI GALT by 15
weeks after oral exposure. Since the initial infection of enteric
nerves occurs substantially before the detection of PrPSc in LI
GALT (9), our data strongly support the conclusion that the LI
GALT are not important early sites of prion neuroinvasion after
oral exposure.
Many factors may exert an important influence on the host’s
susceptibility to oral prion infection. For example, the dramati-
FIG 8 Large intestinal GALT is relatively deficient in the uptake of particulate antigen. Mice were orally gavaged with 2  1011 200-nm fluorescent
microbeads. At 24 h following gavage, the Peyer’s patches, small intestine, cecum, and colon were collected. Cryosections of each were prepared and
counterstained with DAPI to detect cell nuclei (blue). (A) Images of Peyer’s, cecal, and colonic patches showing microbead (green) accumulation.
Microbeads within patches are highlighted with arrows. The follicle-associated epithelium is defined by dotted lines. (B) The number of beads in sections
of Peyer’s (n 96), cecal (n 28), and colonic (n 18) patches from 3 or 4 mice was determined, and the area of GALT was measured to determine the
relative microbead density. Each dot represents the microbead density of an individual patch follicle. Bars display means standard errors of the means
(SEM). (C) Images of small intestinal, cecal, and colonic isolated lymphoid follicles (ILF) showing microbead (green) accumulation. Microbeads within
ILF are highlighted with arrows. The follicle-associated epithelium is defined by dotted lines. (B) The number of beads in small intestinal (n 95), cecal
(n 11), and colonic (n 64) ILF from 4 mice was determined, and the area of GALT was measured to determine the relative microbead density. Each
dot represents the microbead density of an individual ILF. Bars display means SEM. Significant differences were determined by nonparametric ANOVA
(Kruskal-Wallis test) with a Dunn’s multiple comparison post hoc test. ***, P  0.001.
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cally reduced susceptibility of aged mice to oral prion infection
(58) coincides with a significant reduction in the number of ma-
tureMcells in Peyer’s patches anddisturbances to lymphoid tissue
microarchitecture (59, 60). Conversely, chronic inflammation,
through the formation of ectopic FDC-containing B-cell follicles
(tertiary lymphoid tissues), may expand the tissue distribution of
prions within infected hosts (61–63). It is plausible that damage to
the LI mucosa and the associated immune pathology may also
affect oral prion disease pathogenesis (64). Although intestinal
helminth infections are common in animals and humans and
cause significantmorbidity in cattle, sheep, and goats, nothingwas
known about their effects on oral prion disease. Congruent infec-
tion with T. muris did not influence neuroinvasion or disease sus-
ceptibility irrespective of the time at which the mice were coex-
posed with prions, highlighting the important role of SI GALT in
oral prion pathogenesis. Our data appear to contradict those in an
independent study that reported that Salmonella enterica serovar
Typhimurium-induced colitis exacerbated oral prion disease (65).
However, while T. muris is restricted to the LI, subsequent data
have shown that S. Typhimurium infection can also have a dra-
matic effect on M cells and classical dendritic cells in the SI (66,
67), which have key roles in oral prion pathogenesis (26, 27). This
may have significantly influenced prion uptake in the SI, enhanc-
ing disease susceptibility independent of the effects on the LI.
In conclusion, our data demonstrate that the GALT in the SI,
not the LI, are the major early sites of prion accumulation and
neuroinvasion after oral exposure. This has important implica-
tions for our understanding of the factors that influence the risk of
infection and the preclinical diagnosis of disease. Although LI
GALT are not early sites of infection, the detection of PrPSc within
the RAMALT and appendix has proved to be a useful method to
detect prion-infected individuals during the preclinical phase (17,
18, 68) and has been used in the United Kingdom to gain insight
into the possible prevalence of vCJD in the humanpopulation (19,
20). However, our data suggest that the time at which these tissues
are sampled in relation to prion exposure may dramatically affect
the sensitivity of these assays. For instance, humans with subclin-
ical vCJD infection may have only minimal PrP deposition in
appendiceal tissue (69). Together, these data show that analyses of
such biopsy specimens may miss individuals in the early stages of
oral prion infection and underestimate the disease prevalence.
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